Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers.
Wang Z, Cheng S, Yao Y, Liu S, Liu Z, Liu N, Jin Y, Zhang Y, Yin F, Han G, Zhang J, Wang Q, Yan D, Wang L, Lu H, Deng T, Ji Z, Gao H, Fang W, Zhang H, Chen Z, Zou J, Tang Y, Xu C, Li J, Qu H, Bao L, Cao B, Wang X, Xu T, Sun Y, Shen L, Peng Z, Li J.
Wang Z, et al.
Cancer Immunol Immunother. 2024 Jul 5;73(9):182. doi: 10.1007/s00262-024-03764-9.
Cancer Immunol Immunother. 2024.
PMID: 38967817
Free PMC article.